account_id none on file
legal_name CDT Equity Inc.
ticker CDT
cik 1896212
domain conduitpharma.com
linkedin_company_url none on file
entry_point_account_id none on file
name Conduit Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 10 executives 4 family 0
why_nownone on file
callsnone on file
filings
offset by a $0.4 million increase in audit and accounting fees, a $0.1 million increase in travel expenses, and a $0.4 million increase
filing / Aug 12, 2026 / receipt
For the three and six months ended June 30, 2025, the Company incurred director travel expenses payable of $ 0.3 million
filing / Aug 12, 2026 / receipt
offset by a $0.4 million increase in audit and accounting fees, a $0.1 million increase in travel expenses, and a $0.4 million increase
filing / Aug 12, 2026 / receipt
For the three and six months ended June 30, 2025, the Company incurred director travel expenses payable of $ 0.3 million
filing / Aug 12, 2026 / receipt
the years ended December 31, 2025 and 2024, the Company incurred director travel expenses payable to Dr. Regan of approximately $0.4
filing / Aug 11, 2026 / receipt
August 4, 2025, James Bligh was appointed as the permanent Chief Financial Officer of the Company and remains a member of the Company’s
filing / Aug 11, 2026 / receipt
Effective August 4, 2025, James Bligh was appointed as the permanent Chief Financial Officer of the Company
filing / Aug 11, 2026 / receipt
Effective August 4, 2025, James Bligh was appointed as the permanent Chief Financial Officer of the Company and remains a member of the Company’s board of directors.
filing / Aug 11, 2026 / receipt
the years ended December 31, 2025 and 2024, the Company incurred director travel expenses payable to Dr. Regan of approximately $0.4
filing / Aug 11, 2026 / receipt
August 4, 2025, James Bligh was appointed as the permanent Chief Financial Officer of the Company and remains a member of the Company’s
filing / Aug 11, 2026 / receipt
executives
| Andrew Regan | Chief Executive Officer | - | receipt |
| James Bligh | member of the Company’s board of directors | - | receipt |
| Simon Fry | director | - | receipt |
| Ulrik Olsen | director | - | receipt |
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2026-04-27 | director, appointed | sec_8k |
| 2025-04-16 | Chief Executive Officer, appointed | sec_8k |
| 2024-11-19 | director, appointed | sec_8k |
mcp_package_hint
slug conduit-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$